All In MedTech

Device Trial Radar · NCT05662748

Comparison Between Manta and Prostar Closure Devices

Use of the Closure Device in Patient With Percutaneous Transfemoral Aortic Valve Replacement

Last checked: Nov 20, 2026Latest source record: Dec 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

250

Actual

Start

Jan 20, 2020

Primary completion

Mar 30, 2021

Study completion Mar 30, 2021

Sponsor

Lead sponsor
RWTH Aachen UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 22, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Use of the closure device in patient with percutaneous transfemoral aortic valve replacement

Conditions

  • Aortic Valve Stenosis

Interventions

  • Transfemoral aortic valve replacementDevice

    aortic valve replacement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety endpoints during index hospitalisationTime frame: 2018 - 2020
  2. Safety endpoints during index hospitalisation ( bleeding)Time frame: 2018-2020
  3. Safety endpoints during index hospitalisation ( death )Time frame: 2018-2020

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universitätsklinikum Aachen

    Aachen, North Rhine-Westphalia, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.